The global drug discovery informatics market size is
expected to reach USD 2.07 billion by 2025, according to a new report by Grand
View Research, Inc., progressing at a CAGR of 12.6% during the forecast period.
Drug therapy is evolving in response to health care needs of the population.
The most recent trend is to develop drugs for treatment of chronic diseases,
especially those affecting the older population.
Cardiovascular Diseases (CVDs), stroke, and cancer are the most
prevalent health issues and also the most common conditions causing death.
Moreover, treatment expenses and costs pertaining to these diseases are very
high, which triggers the demand for effective novel molecules. In the U.S.
alone, revenue generated through CVD treatments was over USD 444 billion in
2010, and it has been estimated to claim more lives each year than the remaining
causes of death combined.
Clinical decision support tools, which include online database for
assistance in enhancement of clinical decisions, are timely updated and that
significantly impacts market growth. Moreover, the World Health Organization's
Consultative Expert Working Group for Research and Development is also involved
in evaluation and development of open source drug discovery platforms.
Introduction of open drug discovery tool kit (ODDT), which serves as a tool for
computer-aided drug discovery by implementing machine learning scoring
functions (RF-Score and NN-Score), is anticipated to work in favor of the
market.
Full
Research Report On Drug Discovery Informatics Market Analysis:
https://www.grandviewresearch.com/industry-analysis/drug-discovery-informatics-market
https://www.grandviewresearch.com/industry-analysis/drug-discovery-informatics-market
Further key findings from the report suggest:
·
Lead generation and lead optimization are
anticipated to witness hand-in-hand growth owing to usage of similar IT
solutions
·
Presence of different co-operation models,
such as joint ventures, strategic partnership, price competition, and project
selection, for outsourcing drug informatics solutions in the industry is
influencing the growth of the market positively
·
North America is projected to hold
prominent position in the arena throughout the forecast period. Higher
incidence rates of different infectious diseases and oncology diseases are
expected to drive the demand for informatics solutions to aid drug discovery
and development. Presence of molecular R&D laboratories and market players
in the U.S. is supplementing the growth of the regional market
·
Asia Pacific is likely to post the highest
CAGR during the same period, owing to cost saving advantage offered by the
region
·
Some of the key players operating in the
market Boehringer Ingelheim GmBh; ChemAxon; Jubilant Biosys; Certara; Selvita;
Novo Informatics; Albany Molecular Research Inc.; Infosys; DiscoverX;
Collaborative Drug Discovery Inc; GVK Biosciences; and Charles River
Laboratories.
View More Reports
Of This Category By Grand View Research At: https://www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented the global drug discovery informatics
market on the basis of workflow, mode, service, and region:
Drug Discovery
Informatics Workflow Outlook (Revenue, USD Million, 2014 -
2025)
·
Discovery Informatics
o Identification & Validation Informatics Assay
Development Informatics
o Lead Generation Informatics
·
Development Informatics
o Lead Optimization
o FHD Preparation
o Phase IA Informatics
o Phase IB/2 Informatics
Drug Discovery
Informatics Mode Outlook (Revenue, USD Million, 2014 - 2025)
·
In-house Informatics
·
Outsourced Informatics
Drug Discovery
Informatics Service Outlook (Revenue, USD Million, 2014 - 2025)
·
Sequence Analysis Platforms
·
Molecular Modeling
·
Docking
·
Clinical Trial Data Management
·
Others
Drug Discovery
Informatics Regional Outlook (Revenue, USD Million, 2014 - 2025)
·
North America
o U.S.
o Canada
·
Europe
o Germany
o U.K.
·
Asia Pacific
o China
o Japan
·
Latin America
o Brazil
·
Middle East & Africa
o South Africa
Access Full Press
Release of this Report: https://www.grandviewresearch.com/press-release/global-drug-discovery-informatics-market
About Grand View
Research
Grand View Research, Inc. is a U.S. based market research
and consulting company, registered in the State of California and headquartered
in San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
For more information:
https://www.grandviewresearch.com/
No comments:
Post a Comment